New Jersey Senate Bill S308

New Jersey 2022-2023 Regular Session

• Introduced: 1/11/22
• Refer: 1/11/22

Caption

Establishes certain guidelines for health insurance carriers concerning step therapy protocols.

Impact

The proposed legislation is expected to improve patient outcomes by ensuring that healthcare providers maintain the authority to prescribe the most suitable medications for their patients. By streamlining the request process for exceptions to step therapy protocols, the bill aims to reduce administrative burdens and delays in patient care. Additionally, it requires insurance companies to report data about step therapy requests, which will enhance transparency in the decision-making processes involved in drug coverage.

Summary

Senate Bill S308 aims to establish standardized guidelines for health insurance carriers regarding the implementation of step therapy protocols. Step therapy is a common practice where patients are required to try one or more prescribed medications before their insurance covers a medication that their healthcare provider deems necessary. The bill seeks to regulate these protocols to avoid potential harm to patients by ensuring that these guidelines are based on clinical practice standards established by independent experts. Moreover, it mandates that patients must be exempt from step therapy when it is contrary to their health needs.

Contention

However, the bill has faced some contention. Advocates argue that without clear and uniform policies, patients risk receiving inadequate or harmful treatment. On the other hand, critics raise concerns about the potential for increased healthcare costs stemming from the regulations imposed on insurance providers, which could lead to higher premiums for consumers. The balance between maintaining cost control within health insurance while ensuring patient safety and provider authority is at the center of the debate surrounding S308.